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reduction in healthcare costs associated with
tubal infertility, including the costs of in-vitro
fertilisation, constitute an important argument for
the use of DNA amplification technology for the
diagnosis of C. trachomatis.
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ABSTRACT
A cross-sectional study was performed in 60
Cuban women of child-bearing age who were
seropositive for human immunodeficiency virus
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(HIV) and 60 controls. Human papillomavirus
(HPV) was identified most frequently, with on-
cogenic HPV serotypes 16, 33 and 58 detected in
HIV-positive patients, and serotypes 11, 33 and 51
in the controls (relative risk 4.41; 95% CI 2.21–
8.29). Syphilis and hepatitis B and C viruses were
detected exclusively in HIV-seropositive women
(p < 0.05). Sexually transmitted diseases (STDs)
appeared to pose a substantial health problem,
especially for HIV-positive women. Clinics
should consider screening and treatment for STDs
as part of their HIV prevention programmes.
Keywords Cuba, hepatitis virus, human immunode-
ficiency virus, human papillomavirus, sexually trans-
mitted disease, syphilis
Original Submission: 5 January 2005; Revised Sub-
mission: 6 March 2005; Accepted: 2 April 2005
Clin Microbiol Infect 2005; 11: 764–767
10.1111/j.1469-0691.2005.01209.x
The vagina is a common site for sexually trans-
mitted diseases (STDs); however, the correct
diagnosis of an STD may be delayed and ⁄ or
difficult to make, since clinical manifestations are
usually non-specific or even symptomless. As a
consequence, the development of permanent or
severe sequelae, such as infertility or malignant
tumours, is not uncommon. In addition, infections
can be transmitted vertically to infants during
pregnancy or birth [1]. Given the lack of preval-
ence data regarding common STDs in Cuban
women, and the sharp rise in new cases of human
immunodeficiency virus (HIV) infection in Cuba, a
cross-sectional study was performed to define the
prevalence of the most common STDs, as well as
hepatitis B virus (HBV) and hepatitis C virus
(HCV) infection, in 60 Cuban women of child-
bearing age who were seropositive for HIV and
were attending the only outpatient clinic (secon-
dary-care centre) in Cuba for HIV ⁄AIDS patients.
Comparisons were made with 60 HIV-seronega-
tive mothers with no active gynaecological dis-
ease. These women were recruited when they
brought their children to the paediatric depart-
ment of the institute. The two groups of women
had similar age ranges (15–49 years), numbers of
children, behavioural habits and socio-economic
status (Table 1). Of the HIV-seropositive women,
12 had < 500 CD4 cells ⁄ lL, 48 belonged to CDC
group B1-3, and 12 belonged to CDC group C1-3.
Specimens (blood, cervicovaginal (PAP) smears,
vaginal and endocervical swabs) were obtained
from all 120 women and were tested by standard
cultural or serological methods, including HBV
and HCV antibodies (HBV and HBC Ortho
Diagnostics, Raritan, NJ, USA), Treponema pallidum
(haemagglutination test), Ureaplasma (in-house
PCR), Chlamydia (Amplicor PCR Diagnostics;
Roche Diagnostics, Montreal, Quebec, Canada),
Trichomonas vaginalis (Pouch TV culture; Biomed
Diagnostics, San Jose, CA, USA), and Candida and
Neisseria (standard cultural methods). Human
papilloma virus (HPV) PCR (Digene, Gaithers7-
burg, MD, USA) was performed if clinical lesions
were seen on acetic acid testing. Descriptive
statistics were calculated and compared for
women with and without HIV infection. Frequen-
cies were calculated for categorical variables, and
means with corresponding ranges were calculated
for continuous variables. In order to examine the
univariate associations between HIV and specific
risk-factors, relative risk (RR) and corresponding
95% CIs were calculated. Multivariate analysis
between HIV status and HPV positivity was
performed using SPSS v. 6.0 (SPSS Inc., Chicago,
IL, USA).
Table 1. Comparison of microbiological and demographic
data for Cuban women of child-bearing age who were
seropositive or seronegative for human immunodeficiency
virus (HIV)
Characteristic HIV+ HIV– p
Human papillomavirus, no. (%) 33 (55.0) 13 (21.7) < 0.01
Hepatitis C virus, no. (%) 5 (8.3) 0 < 0.05
Hepatitis B virus, no. (%) 4 (6.7) 0 < 0.05
Treponema pallidum, no. (%) 10 (16.7) 0 < 0.01
Ureaplasma spp., no. (%) 20 (33.3) 27 (45.0) NS
Candida albicans, no. (%) 14 (23.3) 10 (16.7) NS
Chlamydia trachomatis, no. (%) 6 (10.0) 4 (6.7) NS
Neisseria gonorrhoeae, no. (%) 0 0 NS
Trichomonas vaginalis, no. (%) 6 (10.0) 1 (1.7) < 0.05
Gardnerella, no. (%) 1 (1.7) 1 (1.7) NS
Women with > 1 STD, no. (%) 31 (51.7) 7 (11.6) < 0.01
Age, years (median and range) 29 (15–49) 26 (15–49) NS
Mean number of children 1.8 2.1 NS
Married, no. (%) 32 (53) 38 (63) NS
Number of sexual partners
in the last 6 months, no. (%)
4 1 < 0.01
Residence in Havana, no. (%) 36 (60) 48 (80) < 0.05
Active smoking, no. (%) 18 (30) 11 (18) NS
Employment, no. (%) 52 (86.6) 57 (95.0) NS
CD4 cells < 500 ⁄mL, no. (%) 12 (20.0) NA
Stage of disease
CDC B, no. (%) 48 (80.0) NA
CDC C, no. (%) 12 (20.0) NA
Evidence of dysplasia
CIN I, no. (%) 6 (10.0) 0
CIN II, no. (%) 1 (1.6) 0
CIN III, no. (%) 0 0
Total number of cases 60 60
NA, not applicable; NS, not significant.
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The study groups were comparable with regard
to behavioural (active smoking, intravenous drug
use) and socio-economic (number of children,
occupation) status. Differences existed in the
mean number of sexual partners in the previous
6 months (HIV-positive, 4; HIV-negative, 1) and
place of residence (36 HIV-positive women lived
in the city of Havana vs. 48 HIV-negative controls;
p < 0.05).
HIV infection was presumably acquired
through heterosexual contact in 58 (96.7%)
women, and by intravenous drug use in two
(3.3%) women (p < 0.001). The results of STD
screening in HIV-seropositive women and the
HIV-negative controls are shown in Table 1.
None of the women had received vaccination
for HBV. The agent identified most frequently
in both groups was HPV, with the oncogenic
serotypes 16, 33 and 58 detected in HIV-positive
women, and serotypes 11, 33 and 51 being
detected most frequently in control patients
(p < 0.01). Women with HIV had a greater risk
of HPV infection (RR 2.5; 95% CI 2.2–8.2) than
the control group. When the HPV prevalence in
both groups was adjusted for variables, the
following variables remained significant: more
than one STD (RR 4.1; 95% CI 2.6–7.4); the
number of sexual partners in the last 6 months
(RR 3.1; 95% CI 2.0–6.1); and occupation as a
sex worker (RR 2.2; 95% CI 1.4–4.8). The PAP
smear was diagnosed as either inflammatory or
positive in 66.7% of HIV-positive women, but in
only 33% of the control group (RR 1.9; 95% CI
1.2–3.2; p < 0.01). Serological test results for
syphilis (p < 0.01), HBV (p < 0.05) and HCV
(p < 0.05) were only positive among HIV-posit-
ive women. T. vaginalis was detected more
frequently in HIV-positive women (RR 3.1;
95% CI 2.1–4.6; p < 0.05), probably because of
the higher number of sexual partners (Table 1).
Neisseria gonorrhoeae was not detected in any
woman in the study. Chlamydia trachomatis,
Ureaplasma spp. and Candida albicans were iso-
lated from women in both groups at similar
frequencies (Table 1).
This study is the first to report on the frequency
of STDs in Cuban women. It is not surprising that
HIV-positive women show a significantly higher
frequency of concomitant STD [2–5]. In addition,
HBV and HCV were detected at significantly
higher frequencies in HIV-positive women. These
viruses may have been transmitted by either
sexual contact or intravenous drug use. The
number of drug users is comparatively low in
Cuba, although this risk-factor is often under-
reported. The data regarding the increased pre-
valence of HPV in HIV-positive women are in
agreement with reports published previously
[6,7]. Overall, the data were in broad agreement
with reports from Kenya, Brazil and Papua New
Guinea, although the prevalences of HPV infec-
tion and hepatitis were not assessed in these
surveys [8–10]. However, trichomoniasis was
considerably less frequent in Cuban women than
in Kenya (25%) and Papua New Guinea (46%)
[8,9].
STDs, as well as HBV and HCV, appear to pose
a substantial health problem among Cuban
women with HIV infection. Clinics should consi-
der screening and treatment for STDs as part of
their HIV prevention programmes; indeed, the
first randomised trial from Tanzania showed that
improved management of bacterial STD, in a
population with relatively low rates of STD,
reduced the incidence of HIV-1 infection
by 40% [11]. Adequate treatment of STDs in
HIV-positive women may result in a better
quality of life and help to prevent the spread of
HIV infection [11].
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ABSTRACT
Infections with verocytotoxigenic Escherichia coli
(VTEC) other than O157 have been assumed to
have the same epidemiology as those with VTEC
O157, but the source of infection is rarely defined
for sporadic cases. This report describes a child
with VTEC O111:H– infection who was probably
infected by playing in a cattle stable and ⁄ or by
drinking raw milk from the cows in this stable. E.
coli O111 isolates colonising the cattle were
indistinguishable from the patient isolate by the
use of serotyping, pulsed-field gel electrophor-
esis, and virulence profiling.
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Several sporadic cases and outbreaks of verocy-
totoxigenic Escherichia coli (VTEC) O157 infections
have been shown to originate from a ruminant
reservoir and to be transmitted via raw milk or
direct contact with cattle [1,2]. Infections with
other VTEC serogroups, e.g., O26 and O111, are
assumed to have the same epidemiology as those
with VTEC O157; that is, the intestinal tract of
cattle is the main reservoir, and transmission to
man occurs either by direct contact with cattle or
the contaminated environment, or via consump-
tion of contaminated meat, milk, vegetables, fruit
or water [3]. However, cases of non-O157 VTEC
infections have rarely been shown to originate
directly from a specific cattle herd.
This report describes a case of VTEC O111
infection in a child, who was probably infected by
playing in a cattle stable and ⁄ or by drinking raw
milk from the cows in this stable. The patient, a girl
aged 16 months, was taken to the general practi-
tioner after 10 days of non-bloody diarrhoea
accompanied by vomiting for 1 day. The girl was
previously healthy and had not received any
antimicrobial chemotherapy in the 2 weeks pre-
ceding the start of gastrointestinal symptoms. She
did not suffer any other concomitant symptoms or
complications, and recovered spontaneously
2 weeks after the start of symptoms.A stool sample
was examined routinely for bacterial pathogens,
including pathogenic E. coli, by plating on to
Statens Serum Institut enteric medium [4] and
screening for colonies with E. coli virulence factors
by dot-blot DNA hybridisation (including DNA
probes for the vtx1, vtx2 and eae genes). Isolates
positive for vtx were O:H-serotyped with E. coli
antisera (Statens Serum Institut, Copenhagen,
Denmark).
An O111:H– isolate was obtained from the
child’s stool sample. As a VTEC isolate was
detected, the parents of the child were interviewed
to obtain information on likely transmission routes.
It was revealed that the child had visited a farm
1 day before symptoms started, and that during
this visit she had drunk unpasteurised milk and
had been playing in the cowshed without sub-
sequent handwashing. It iswell-known that awide
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